Vimarsana
Biggest News Aggregation in the World

Page 2 - Dosing Interval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dosing Interval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dosing Interval Today - Breaking & Trending Today

MSNBC Craig Melvin Reports October 15, 2021 15:01:00 - Vimarsana News

MSNBC Craig Melvin Reports October 15, 2021 15:01:00

Us on this. we appreciate it. let's talk about what the fd sa meeting on today, the johnson & johnson booster. a recommendation from the studies of johnson & johnson. this booster to be administered two to six months after that initial dose. of course, we know that's different than moderna and pfizer recommendations for them. talk me through what you expect to hear today from the fda when it comes to the johnson & johnson booster. >> good morning. great to be here. we've been talking to the 15 million americans who received one shot of johnson & johnson and formally about this issue for many m...

FOXNEWS America Reports With John Roberts Sandra Smith September 24, 2021 17:34:00 - Vimarsana News

FOXNEWS America Reports With John Roberts Sandra Smith September 24, 2021 17:34:00

In the fisa vaccine efficacy against breakthrough infections. that's distracting and there are some unintended harm of giving of does to people who are young and healthy. we have seen that with young boys at a high rate of one and 6,000, and there is no global equity issue. so it is distracting and is interfering with the global equity issue and i think it's not a good time to be talking about boosters for young healthy people. >> john: one of the things that you have talked about frequently is the spacing of vaccine doses. you have an editorial in mid page today where you say there is a growi...

MSNBC Katy Tur Reports September 3, 2021 18:38:00 - Vimarsana News

MSNBC Katy Tur Reports September 3, 2021 18:38:00

If you have one shot j&j, and what is the right dosing interval, two months? six months? we don't know. that is number one. what about moderna, and you need the third dose? a half concentration dose or the full concentration dose? we don't know. mixing and matching? we haven't levied a recommendation yet here in the united states of mixing and matching johnson & johnson and moderna or pfizer, and so there are critical unknowns here right now, geoff. the only known that we do know is that if you are giving an additional shot of moderna or pfizer, and if you are immunocompromised, the narrow gro...

MSNBC Katy Tur Reports September 3, 2021 18:37:00 - Vimarsana News

MSNBC Katy Tur Reports September 3, 2021 18:37:00

Has confirmed that officials are advising the white house to scale back the plan for booster shots, because you have said that vaccinating the rest of the world first before giving the americans a third dose is the best way to go. help us to understand that view, and what are you saying to the people who say that is all well and good, but i want to be as protected as possible. >> so, you know, a key piece here, geoff, narrowing the definition of who gets a booster who versus doesn't get a booster. it is important for the public trust. what we know is that getting a second, getting a third shot...

Interval between Pfizer-BioNTech doses can stretched to six weeks, says Khairy - Vimarsana News

Interval between Pfizer-BioNTech doses can stretched to six weeks, says Khairy

PETALING JAYA: The interval between the first and second dose of the Pfizer-BioNTech Covid-19 vaccine can be stretched from three weeks to six weeks apart unless there is a variant of concern in the area, says Khairy Jamaluddin. "Even though the strategy from three weeks to six weeks will allow us to administer the vaccine to more people, we also have to look at variants of concern which will impact the efficacy of the vaccine," the National Covid-19 Immunisation Programme coordinating minister said during a virtual press conference on Thursday (May 27). Khairy added that data from Pfizer-Bio...